Serum amyloid A induces mitogenic signals in regulatory T cells via monocyte activation

Molecular Immunology

Volumn 59, Issue 2, 2014, Pages 172-179

  Nguyen, Khoa D ^a   Macaubas, Claudia ^a   Truong, Phi ^a   Wang, Nan ^a   Hou, Tieying ^a   Yoon, Taejin ^a   Mellins, Elizabeth D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IL 1 ; IL 6; Monocytes; Regulatory T cells; Serum amyloid A

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOKINE; PROTEIN KINASE B; SERUM AMYLOID A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; MONOCYTE; MONOCYTE ACTIVATION; MONOCYTE CULTURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

IL-1Β; IL-6; MONOCYTES; REGULATORY T CELLS; SERUM AMYLOID A;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGENS; MONOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; SERUM AMYLOID A PROTEIN; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84895983526     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.02.011     Document Type: Article

References (40)

1. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
2. Baecher-Allan C., Wolf E., Hafler D.A. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 2006, 176:4622-4631.
3. Baranova I.N., Vishnyakova T.G., Bocharov A.V., Kurlander R., Chen Z., Kimelman M.L., Remaley A.T., Csako G., Thomas F., Eggerman T.L., Patterson A.P. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 2005, 280:8031-8040.
4. Beriou G., Costantino C.M., Ashley C.W., Yang L., Kuchroo V.K., Baecher-Allan C., Hafler D.A. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009, 113:4240-4249.
5. + T cells without reversing their suppressive function. J. Immunol. 2005, 175:7332-7340.
6. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 2004, 6:335-346.
7. Cheng N., He R., Tian J., Ye P.P., Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008, 181:22-26.
8. Cocco E., Bellone S., El-Sahwi K., Cargnelutti M., Buza N., Tavassoli F.A., Schwartz P.E., Rutherford T.J., Pecorelli S., Santin A.D. Serum amyloid A: a novel biomarker for endometrial cancer. Cancer 2010, 116:843-851.
9. Deknuydt F., Bioley G., Valmori D., Ayyoub M. IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin. Immunol. 2009, 131:298-307.
10. De Santo C., Arscott R., Booth S., Karydis I., Jones M., Asher R., Salio M., Middleton M., Cerundolo V. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol. 2010, 11:1039-1046.
11. + CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 2004, 172:6435-6443.
12. + immune regulatory network. Blood 2006, 107:1696-1702.
13. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
14. Eklund K., Niemi K., Kovanen P. Immune functions of serum amyloid A. Crit. Rev. Immunol. 2012, 32:335-348.
15. Hofmann M.A., Drury S., Hudson B.I., Gleason M.R., Qu W., Lu Y., Lalla E., Chitnis S., Monteiro J., Stickland M.H., Bucciarelli L.G., Moser B., Moxley G., Itescu S., Grant P.J., Gregersen P.K., Stern D.M., Schmidt D.M. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002, 3:123-135.
16. He R.L., Zhou J., Hanson C.Z., Chen J., Cheng N., Ye R.D. Serum amyloid A induces G-CSF expression and neutrophilia via toll-like receptor 2. Blood 2009, 113:429-437.
17. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000, 192:1213-1222.
18. Khan A., Dovedi S., Wilkinson R., Pritchard D. Tumor infiltrating regulatory T cells: tractable targets for immunotherapy. Int. Rev. Immunol. 2010, 29:461-484.
19. Kishimoto T. IL-6: from its discovery to clinical applications. Int. Immunol. 2010, 22:347-352.
20. Kubo T., Hatton R.D., Oliver J., Liu X., Elson C.O., Weaver C.T. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 2004, 173:7249-7258.
21. Kutukculer N., Caglayan S., Aydogdu F. Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin. Rheumatol. 1998, 17:288-292.
22. Lang R., Pauleau A.L., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., Murray P.J. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 2003, 4:546-550.
23. + T cells by bone marrow-derived dendritic cells. Immunology 2009, 127:50-61.
24. Martini A. Systemic juvenile idiopathic arthritis. Autoimmun. Rev. 2012, 12:56-59.
25. Misch E.A., Hawn T. Toll-like receptor polymorphisms and susceptibility to human disease. Clin. Sci. 2008, 114:347-360.
26. Nguyen K.D., Macaubas C., Nadeau K.C., Truong P., Yoon T., Lee T., Park J.L., Mellins E.D. Serum amyloid A overrides Treg anergy via monocyte dependent and Treg-intrinsic, SOCS3-associated pathways. Blood 2011, 117:3793-3798.
27. Obici L., Merlini G. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med. Wkly. 2012, 142:w13580.
28. Okamoto H., Katagiri Y., Kiire A., Momohara S., Kamatani N. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J. Rheumatol. 2008, 35:752-756.
29. O'Sullivan B.J., Thomas H.E., Pai S., Santamaria P., Iwakura Y., Steptoe R.J., Kay T.W., Thomas R. IL-1β breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 2006, 176:7278-7287.
30. + T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
31. Sandri S., Rodriguez D., Gomes E., Monteiro H.P., Russo M., Campa A. Is serum amyloid A an endogenous TLR4 agonist?. J. Leukoc. Biol. 2008, 83:1174-1180.
32. Saxena N., Aggarwal A., Misra R. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. J. Rheumatol. 2005, 32:1349-1353.
33. Shim J.W., Jo S.H., Kim S.D., Lee H.Y., Yun J., Bae Y.S. Lysophosphatidylglycerol inhibits formyl peptide receptorlike-1-stimulated chemotactic migration and IL-1beta production from human phagocytes. Exp. Mol. Med. 2009, 41:584-591.
34. Sikora K.A., Grom A.A. Update on the pathogenesis and treatment of systemic idiopathic arthritis. Curr. Opin. Pediatr. 2011, 23:640-646.
35. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 1994, 15:81-88.
36. Walter G.J., Evans H.G., Menon B., Gullick N.J., Kirkham B.W., Cope A.P., Geissmann F., Taams L.S. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4(+) CD45RO(+) CD25(+) CD127(low) regulatory T cells. Arthritis Rheum. 2013, 65:627-638.
37. Wong P.K., Egan K.P., Croker B., O'Donnell K., Sims N., Drake S., Kiu H., McManus E., Alexander W., Roberts A., Wicks I. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J. Clin. Invest. 2006, 116:1571-1581.
38. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat. Clin. Pract. Rheumatol. 2006, 2:28-34.
39. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003, 198:235-247.
40. Yoshimura A., Naka T., Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 2007, 7:454-465.